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1. INTRODUCTION {#clc23276-sec-0005}
===============

Scrub typhus is a well‐known, seasonal infection caused by *Orientia tsutsugamushi*, which mainly confined to Southeastern Asia and the Western Pacific rim.[1](#clc23276-bib-0001){ref-type="ref"}, [2](#clc23276-bib-0002){ref-type="ref"} Recently, the geographical distribution of its endemic area has been widening with its overall mortality rate increasing. However, scrub‐typhus‐induced adverse cardiovascular complications remain remarkably under‐recognized.[3](#clc23276-bib-0003){ref-type="ref"} The majority of scrub typhus infections resolve with proper antibiotics and supportive treatment without any complications.[4](#clc23276-bib-0004){ref-type="ref"} However, with regards to scrub typhus infection complications,[5](#clc23276-bib-0005){ref-type="ref"}, [6](#clc23276-bib-0006){ref-type="ref"}, [7](#clc23276-bib-0007){ref-type="ref"} the overall mortality rate has been reported to range from overall 16% to 30%, which might be attributed to cardiovascular complications.[8](#clc23276-bib-0008){ref-type="ref"}, [9](#clc23276-bib-0009){ref-type="ref"} In particular, new‐onset atrial fibrillation (AF) has been reported as a poor prognostic factor in common infectious disorders,[10](#clc23276-bib-0010){ref-type="ref"}, [11](#clc23276-bib-0011){ref-type="ref"} which points to the need for investigating the association between scrub typhus infection and subsequent adverse cardiac events. New‐onset AF, acute heart failure (AHF), and ischemic heart disease (IHD) have been recognized as the major cardiac manifestations of public health adverse outcomes and the primary end points of infection‐induced cardiovascular outcomes.[11](#clc23276-bib-0011){ref-type="ref"}, [12](#clc23276-bib-0012){ref-type="ref"}, [13](#clc23276-bib-0013){ref-type="ref"} Therefore, we investigated whether new‐onset AF was significantly associated with 3‐month mortality and concurrent AHF and IHD in a nationwide cohort of scrub typhus infection.

2. METHODS {#clc23276-sec-0006}
==========

2.1. Data source {#clc23276-sec-0007}
----------------

This study used data from the National Health Information Database (NHID) from 2006 to 2016. This is a public database on healthcare utilization, health screening, sociodemographic variables, and mortality for the entire population of South Korea (hereafter referred to as "Korea"), which was formed by the National Health Insurance Service (NHIS).[14](#clc23276-bib-0014){ref-type="ref"} Under universal medical coverage, all medical claims data are collected by the NHIS as the single insurer in Korea; therefore, all individuals included in the NHID were followed until 2017 unless there was a death or disqualification from National Health Insurance for an appropriate reason, such as emigration. The NHID includes an eligibility database, a national health screening database, a healthcare utilization database, a long‐term care insurance database, and a healthcare provider database.[14](#clc23276-bib-0014){ref-type="ref"} The healthcare utilization database is based on data collected during the processing of healthcare claims for services used and includes records of inpatient and outpatient usage (diagnosis, length of stay, treatment costs, services received) and prescription records (drug code, days prescribed, daily dosage).[14](#clc23276-bib-0014){ref-type="ref"} Access to the NHID can be obtained through the Health Insurance Data Service home page \[<http://nhiss.nhis.or.kr>\].

2.2. Sample size and collection {#clc23276-sec-0008}
-------------------------------

The population included in the NHID was over 49 million in 2006 and 51 million in 2016. From the NHID, during 2006 to 2016, a total of 240 329 patients with scrub typhus were selected using three criteria: (a) diagnosis code of ICD‐10 A753 (typhus fever due to *Rickettsia tsutsugamushi*), A752 (typhus fever due to *Rickettsia typhi*), or A759 (typhus fever, unspecified); (b) prescription of doxycycline or azithromycin for at least 3 days; and (c) 20 years of age or over at the time of diagnosis.[12](#clc23276-bib-0012){ref-type="ref"} In order to detect relevant cases, 2661 patients were excluded due to prior history of AF or acute myocarditis. Additionally, 4195 patients with missing values were excluded. Finally, a total of 233 473 patients with scrub typhus were selected as study participants. The index date (date of diagnosis) was defined as the date of first prescription.

2.3. Definition of new‐onset atrial fibrillation, acute heart failure, ischemic heart disease, and mortality {#clc23276-sec-0009}
------------------------------------------------------------------------------------------------------------

New‐onset AF was defined with a diagnosis code of ICD‐10 I48 (paroxysmal AF) within 30 days of the index date and no prior history of AF. New‐onset AHF was defined by a diagnosis code of ICD‐10 I40 (acute myocarditis), I30 (acute pericarditis), or I50 (heart failure) within 30 days of the index date. To exclude AHF induced by IHD, patients treated with coronary bypass graft surgery, primary coronary intervention, or thrombolytic agents (streptokinase, urokinase, tenecteplase) were further excluded. New‐onset IHD was defined as: (a) a diagnosis code of ICD‐10 I21 (acute myocardial infarction) or I20 (angina pectoris) within 30 days of the index date; and (b) treatment with coronary bypass graft surgery, primary coronary intervention, or thrombolytic agents (streptokinase, urokinase, tenecteplase). Three‐month all‐cause mortality was defined as death due to any cause within 90 days of the index date. Dates of deaths were obtained using each participant\'s unique, de‐identified number code, which is linked to mortality information from the Korean National Statistical Office.

2.4. Statistical analysis {#clc23276-sec-0010}
-------------------------

To assess the association between new‐onset AF and the risk of AHF, IHD, and 30‐day mortality, a generalized estimating equation model with a Poisson distribution and logarithmic link function was used to estimate adjusted risk ratios (RRs) and 95% confidence intervals (CIs). Potential confounders were adjusted for using multivariable‐adjusted regression models. The participants\' level of comorbidities were assessed using the diagnostic codes during the three years prior to the index date using the Quan\'s International Statistical Classification of Disease and Related Health Problems, 10th Revision (ICD‐10) coding algorithm of the Charlson Comorbidity Score (CCS).[15](#clc23276-bib-0015){ref-type="ref"} The presence of the disease categories AHF, IHD, stroke, chronic kidney disease, diabetes mellitus, hypertension, and malignancy were defined based on at least two outpatient visits or one inpatient admission with the corresponding primary or secondary diagnosis codes.

Statistical analyses were conducted using SAS software, version 9.4 (SAS Institute, Cary, North Carolina). A *P* value less than .05 was considered statistically significant.

3. RESULTS {#clc23276-sec-0011}
==========

3.1. Baseline characteristics {#clc23276-sec-0012}
-----------------------------

Most of the patients within the scrub typhus cohort were female residents (41.1%, male) in non‐metropolitan areas (75.0%) treated with doxycycline (93.7%). These patients and had low incidence of previous HF (1.2%), previous IHD (5.9%), chronic kidney disease (0.4%), diabetes (13.3%), or a CCS over three (5.1%).

3.2. Incidence of new‐onset AF {#clc23276-sec-0013}
------------------------------

Of the 233 473‐scrub typhus infection records in the cohort, 2402 (1.0%) patients were diagnosed as having new‐onset AF during treatment for scrub typhus infection. Those with new‐onset AF tended to be over the age of 60 (87.2%) with significantly higher incidences of intensive care unit (ICU) hospitalization (7.7% vs 0.9%), previous HF (5.8% vs 1.2%), previous IHD (10.7% vs 5.9%), previous stroke (7.9% vs 3.5%), chronic kidney disease (1.0% vs 0.4%), diabetes (17.1% vs 13.2%), and hypertension (54.0% vs 34.0%) compared to those without new‐onset AF (Table [1](#clc23276-tbl-0001){ref-type="table"}).

###### 

Baseline characteristics of scrub typhus patients with and without new‐onset atrial fibrillation

  Variables                        Total 233 473     With new‐onset AF 2402   Without AF 231 071   P
  -------------------------------- ----------------- ------------------------ -------------------- ---------
  **Age**                                                                                          \<.0001
  20‐49                            48 519 (20.7%)    109 (4.5%)               48 410 (20.9%)       
  50‐59                            53 480 (22.9%)    199 (8.2%)               53 281 (23.0%)       
  60‐69                            60 676 (25.9%)    537 (22.3%)              60 139 (26.0%)       
  70‐79                            53 648 (22.9%)    972 (40.4%)              52 676 (22.8%)       
  Over 80                          17 150 (7.35%)    585 (24.3%)              16 565 (7.1%)        
  **Sex**                                                                                          0.0315
  Male                             96 071 (41.1%)    1040 (43.3%)             95 031 (41.1%)       
  Female                           137 402 (58.8%)   1362 (56.7%)             136 040 (58.8%)      
  **Insurance**                                                                                    
  Medical aids                     12 883 (5.5%)     207 (8.6%)               12 676 (5.4%)        
  Health insurance                                                                                 \<.0001
  1Q                               38 844 (16.6%)    374 (15.5%)              38 470 (16.6%)       
  2Q                               42 517 (18.2%)    383 (15.9%)              42 134 (18.2%)       
  3Q                               58 837 (25.2%)    517 (21.5%)              58 320 (25.2%)       
  4Q                               80 392 (34.4%)    921 (38.3%)              79 471 (34.3%)       
  **Residential area**                                                                             0.1446
  Metropolitan                     58 200 (24.9%)    568 (23.6%)              57 632 (24.9%)       
  Non‐metropolitan                 175 273 (75.0%)   1834 (76.3%)             173 439 (75.0%)      
  **Institution**                                                                                  \<.0001
  Outpatient care                  96 057 (41.1%)    66 (2.7%)                95 991 (41.5%)       
  **Admission**                                                                                    
  Less 300                         84 847 (36.3%)    982 (40.8%)              83 865 (36.2%)       
  300‐799                          43 253 (18.5%)    1077 (44.8%)             42 176 (18.2%)       
  Over 800                         9316 (3.9%)       277 (11.5%)              9039 (3.9%)          
  **Antibiotics**                                                                                  \<.0001
  Doxycycline                      218 791 (93.7%)   1932 (80.4%)             216 859 (93.8%)      
  Azithromycin                     8910 (3.8%)       227 (9.4%)               8683 (3.7%)          
  Both                             5772 (2.4%)       243 (10.1%)              5529 (2.3%)          
  **ICU care**                                                                                     \<.0001
  Yes                              2342 (0.1%)       185 (7.7%)               2157 (0.9%)          
  **Medical history**                                                                              
  Past scrub typhus                                                                                \<.0001
  Yes                              7300 (3.1%)       42 (1.7%)                7258 (3.1%)          
  Congestive heart failure                                                                         \<.0001
  Yes                              2973 (1.2%)       140 (5.8%)               2833 (1.2%)          
  Ischemic heart disease                                                                           \<.0001
  Yes                              13 995 (5.9%)     258 (10.7%)              13 737 (5.9%)        
  Stroke                                                                                           \<.0001
  Yes                              8355 (3.5%)       190 (7.9%)               8165 (3.5%)          
  Chronic kidney disease                                                                           \<.0001
  Yes                              1121 (0.4%)       26 (1.0%)                1095 (0.4%)          
  Diabetes mellitus                                                                                \<.0001
  Yes                              31 072 (13.3%)    412 (17.1%)              30 660 (13.2%)       
  Hypertension                                                                                     \<.0001
  Yes                              80 059 (34.2%)    1299 (54.0%)             78 760 (34.0%)       
  Malignancy                                                                                       0.7353
  Yes                              9979 (4.2%)       106 (4.4%)               9873 (4.2%)          
  **Charlson Comorbidity Score**                                                                   \<.0001
  0                                142 097 (60.8%)   1227 (51.0%)             140 870 (60.9%)      
  1                                57 174 (24.4%)    710 (29.5%)              56 464 (24.4%)       
  2                                22 228 (9.5%)     294 (12.2%)              21 934 (9.4%)        
  Over 3                           11 974 (5.1%)     171 (7.1%)               11 803 (5.1%)        
  **Calendar year**                                                                                \<.0001
  2006                             22 470 (9.6%)     221 (9.2%)               22 249 (9.6%)        
  2007                             19 413 (8.3%)     187 (7.7%)               19 226 (8.3%)        
  2008                             21 238 (9.0%)     199 (8.2%)               21 039 (9.1%)        
  2009                             22 726 (9.7%)     197 (8.2%)               22 529 (9.7%)        
  2010                             19 924 (8.5%)     228 (9.4%)               19 696 (8.5%)        
  2011                             18 435 (7.8%)     180 (7.4%)               18 255 (7.9%)        
  2012                             24 784 (10.6%)    230 (9.5%)               24 554 (10.6%)       
  2013                             24 547 (10.5%)    241 (10.0%)              24 306 (10.5%)       
  2014                             17 916 (7.6%)     243 (10.0%)              17 673 (7.6%)        
  2015                             20 397 (8.7%)     303 (12.6%)              20 094 (8.7%)        
  2016                             21 623 (9.2%)     173 (7.2%)               21 450 (9.2%)        

3.3. Incidence risk ratio for cardiovascular complication {#clc23276-sec-0014}
---------------------------------------------------------

Those with new‐onset AF had an incidence risk ratio (IRR) of 4.1 for AHF within a few days of scrub typhus infection diagnosis compared with those without new‐onset AF (Figure [1](#clc23276-fig-0001){ref-type="fig"}A). Furthermore, patients over 50 years of age had an increased IRR of 2.0 to 5.4 for AHF. Patients admitted to the ICU or having a previous diagnosis of HF or IHD had an IRR for AHF of 2.4, 2.2, and 1.2, respectively, after being adjusted for demographic factors and comorbidities (Table [2](#clc23276-tbl-0002){ref-type="table"}).

![Comparison of survival rate free from, A, acute heart failure, B, ischemic heart disease, C, all‐cause mortality in patients diagnosed as scrub typhus between with and without new‐onset atrial fibrillation (NAF)](CLC-42-1210-g001){#clc23276-fig-0001}

###### 

Incidence risk ratio for the occurrence of acute heart failure according to the development of new‐onset atrial fibrillation among scrub typhus patients

                                   Cumulative incidence   Crude model   Adjusted model                                                                  
  -------------------------------- ---------------------- ------------- ---------------- ----------- ------- ------- --------- ---------- ------ ------ ---------
  **New‐onset AF**                                                                                                                                      
  No                               3273                   231 071       1.42             1.00                                  1.00                     
  Yes                              446                    2402          18.57            **13.11**   11.98   14.35   \<.0001   **4.12**   4.55   3.73   \<.0001
  **Age**                                                                                                                                               
  20‐49                            235                    48 519        0.48             1.00                                  1.00                     
  50‐59                            349                    53 480        0.65             **1.35**    1.14    1.59    .0004     **1.27**   1.49   1.07   .0052
  60‐69                            711                    60 676        1.17             **2.42**    2.09    2.80    \<.0001   **2.02**   2.35   1.74   \<.0001
  70‐79                            1450                   53 648        2.70             **5.58**    4.86    6.40    \<.0001   **3.59**   4.15   3.10   \<.0001
  Over 80                          974                    17 150        5.68             **11.73**   10.18   13.51   \<.0001   **5.46**   6.36   4.69   \<.0001
  **Sex**                                                                                                                                               
  Male                             1335                   96 071        1.39             **0.80**    0.75    0.86    \<.0001   **0.94**   1.00   0.88   .0536
  Female                           2384                   137 402       1.74             1.00                                  1.00                     
  **Insurance**                                                                                                                                         
  Medical aids                     352                    12 883        2.73             1.00                                  1.00                     
  Health insurance                                                                                                                                      
  1Q                               630                    38 844        1.62             **0.59**    0.52    0.68    \<.0001   **0.89**   1.01   0.78   .0737
  2Q                               531                    42 517        1.25             **0.46**    0.40    0.52    \<.0001   **0.78**   0.89   0.68   .0002
  3Q                               803                    58 837        1.36             **0.50**    0.44    0.57    \<.0001   **0.80**   0.91   0.71   .0004
  4Q                               1403                   80 392        1.75             **0.64**    0.57    0.72    \<.0001   **0.78**   0.88   0.70   \<.0001
  **Residential area**                                                                                                                                  
  Metropolitan                     865                    58 200        1.49             1.00                                  1.00                     
  Non‐metropolitan                 2854                   175 273       1.63             **0.91**    0.85    0.98    .0178     **0.97**   1.05   0.90   .5052
  **Institution**                                                                                                                                       
  Outpatient care                  115                    96 057        0.12             1.00                                  1.00                     
  **Antibiotics**                                                                                                                                       
  Doxycycline                      3016                   218 791       1.38             1.00                                  1.00                     
  Azithromycin                     382                    8910          4.29             **3.11**    2.80    3.45    \<.0001   **1.59**   1.77   1.43   \<.0001
  Both                             321                    5772          5.56             **4.03**    3.61    4.51    \<.0001   **1.52**   1.70   1.35   \<.0001
  **ICU care**                                                                                                                                          
  No                               3510                   231 131       1.52             1.00                                  1.00                     
  Yes                              209                    2342          8.92             **5.88**    5.14    6.72    \<.0001   **2.46**   2.84   2.13   \<.0001
  **Medical history**                                                                                                                                   
  Past scrub typhus                                                                                                                                     
  No                               3628                   226 173       1.60             1.00                                  1.00                     
  Yes                              91                     7300          1.25             **0.78**    0.63    0.96    .0169     **0.81**   0.99   0.66   .0417
  Congestive heart failure                                                                                                                              
  No                               3492                   230 500       1.52             1.00                                  1.00                     
  Yes                              227                    2973          7.64             **5.04**    4.43    5.74    \<.0001   **2.20**   2.53   1.92   \<.0001
  Ischemic heart disease                                                                                                                                
  No                               3251                   219 478       1.48             1.00                                  1.00                     
  Yes                              468                    13 995        3.34             **2.26**    2.05    2.48    \<.0001   **1.28**   1.42   1.16   \<.0001
  Stroke                                                                                                                                                
  No                               3439                   225 118       1.53             1.00                                  1.00                     
  Yes                              280                    8355          3.35             **2.19**    1.95    2.47    \<.0001   **1.09**   1.23   0.96   .1742
  Chronic kidney disease                                                                                                                                
  No                               3673                   232 352       1.58             1.00                                  1.00                     
  Yes                              46                     1121          4.10             **2.60**    1.95    3.45    \<.0001   **1.05**   1.42   0.78   .7467
  Diabetes mellitus                                                                                                                                     
  No                               2978                   202 401       1.47             1.00                                  1.00                     
  Yes                              741                    31 072        2.38             **1.62**    1.50    1.76    \<.0001   **1.02**   1.10   0.94   .6843
  Hypertention                                                                                                                                          
  No                               1713                   153 414       1.12             1.00                                  1.00                     
  Yes                              2006                   80 059        2.51             **2.24**    2.11    2.39    \<.0001   **1.16**   1.25   1.08   \<.0001
  Malignancy                                                                                                                                            
  No                               3539                   223 494       1.58             1.00                                  1.00                     
  Yes                              180                    9979          1.80             **1.14**    0.98    1.32    .0852     **0.86**   1.02   0.72   .0767
  **Charlson Comorbidity Score**                                                                                                                        
  0                                1838                   142 097       1.29             1.00                                  1.00                     
  1                                1036                   57 174        1.81             **1.40**    1.30    1.51    \<.0001   **0.95**   1.02   0.88   .1554
  2                                544                    22 228        2.45             **1.89**    1.72    2.08    \<.0001   **1.09**   1.21   0.99   .0896
  Over 3                           301                    11 974        2.51             **1.94**    1.72    2.19    \<.0001   **0.96**   1.11   0.83   .5876

Those with new‐onset AF had an IRR of 1.9 for IHD compared with those without new‐onset AF (Figure [1](#clc23276-fig-0001){ref-type="fig"}B). Patients over the age of 50 also had an increased IRR for IHD of 2.9 to 14.6. Those admitted to the ICU, or having a past scrub typhus infection, HF or IHD had an IRR for IHD of 5.6, 2.0, 1.5, and 2.0, respectively, after being adjusted for demographic factors and comorbidities (Table [3](#clc23276-tbl-0003){ref-type="table"}).

###### 

Incidence risk ratio for the occurrence of ischemic heart disease according to the development of new‐onset atrial fibrillation among scrub typhus patients

                                   Cumulative incidence   Crude model   Adjusted model                                                                    
  -------------------------------- ---------------------- ------------- ---------------- ----------- ------- ------- --------- ----------- ------- ------ ---------
  **New‐onset AF**                                                                                                             1.00                       
  No                               278                    231 071       0.12             1.00                                                             
  Yes                              27                     2402          1.12             **9.34**    6.31    13.84   \<.0001   **1.95**    3.04    1.25   .0032
  **Age**                                                                                                                                                 
  20‐49                            8                      48 519        0.02             1.00                                  1.00                       
  50‐59                            26                     53 480        0.05             **2.95**    1.34    6.51    .0075     **2.99**    6.64    1.35   .0071
  60‐69                            65                     60 676        0.11             **6.50**    3.12    13.54   \<.0001   **5.45**    11.51   2.58   \<.0001
  70‐79                            128                    53 648        0.24             **14.47**   7.08    29.56   \<.0001   **9.60**    19.94   4.62   \<.0001
  Over 80                          78                     17 150        0.45             **27.58**   13.33   57.09   \<.0001   **14.65**   31.00   6.92   \<.0001
  **Sex**                                                                                                                                                 
  Male                             164                    96 071        0.17             **1.66**    1.33    2.08    \<.0001   **1.96**    2.46    1.56   \<.0001
  Female                           141                    137 402       0.10             1.00                                  1.00                       
  **Insurance**                                                                                                                                           
  Medical aids                     42                     12 883        0.33             1.00                                  1.00                       
  Health insurance                                                                                                                                        
  1Q                               47                     38 844        0.12             **0.37**    0.24    0.56    \<.0001   **0.61**    0.92    0.40   .0197
  2Q                               44                     42 517        0.10             **0.32**    0.21    0.48    \<.0001   **0.55**    0.86    0.36   .0078
  3Q                               61                     58 837        0.10             **0.32**    0.21    0.47    \<.0001   **0.51**    0.77    0.34   .0013
  4Q                               111                    80 392        0.14             **0.42**    0.30    0.60    \<.0001   **0.52**    0.74    0.36   .0003
  **Residential area**                                                                                                                                    
  Metropolitan                     81                     58 200        0.14             1.00                                  1.00                       
  Non‐metropolitan                 224                    175 273       0.13             **1.09**    0.84    1.40    .5105     **1.16**    1.50    0.90   .2538
  **Institution**                                                                                                                                         
  Outpatient care                  19                     96 057        0.02             1.00                                  1.00                       
  **Antibiotics**                                                                                                                                         
  Doxycycline                      221                    218 791       0.10             1.00                                  1.00                       
  Azithromycin                     35                     8910          0.39             **3.89**    2.72    5.55    \<.0001   **1.97**    2.86    1.35   .0004
  Both                             49                     5772          0.85             **8.40**    6.17    11.44   \<.0001   **3.45**    4.79    2.48   \<.0001
  **ICU care**                                                                                                                                            
  No                               259                    231 131       0.11             1.00                                  1.00                       
  Yes                              46                     2342          1.96             **17.53**   12.84   23.92   \<.0001   **5.63**    7.99    3.97   \<.0001
  **Medical history**                                                                                                                                     
  Past scrub typhus                                                                                                                                       
  No                               289                    226 173       0.13             1.00                                  1.00                       
  Yes                              16                     7300          0.22             **1.72**    1.04    2.84    .0354     **2.08**    3.44    1.25   .0046
  Congestive heart failure                                                                                                                                
  No                               290                    230 500       0.13             1.00                                  1.00                       
  Yes                              15                     2973          0.50             **4.01**    2.39    6.73    \<.0001   **1.50**    2.54    0.88   .1342
  Ischemic heart disease                                                                                                                                  
  No                               247                    219 478       0.11             1.00                                  1.00                       
  Yes                              58                     13 995        0.41             **3.68**    2.77    4.90    \<.0001   **2.00**    2.71    1.47   \<.0001
  Stroke                                                                                                                                                  
  No                               281                    225 118       0.12             1.00                                  1.00                       
  Yes                              24                     8355          0.29             **2.30**    1.52    3.49    \<.0001   **0.94**    1.45    0.61   .7672
  Chronic kidney disease                                                                                                                                  
  No                               293                    232 352       0.13             1.00                                  1.00                       
  Yes                              12                     1121          1.07             **8.49**    4.78    15.07   \<.0001   **2.67**    5.16    1.38   .0035
  Diabetes mellitus                                                                                                                                       
  No                               232                    202 401       0.11             1.00                                  1.00                       
  Yes                              73                     31 072        0.23             **2.05**    1.58    2.67    \<.0001   **1.22**    1.62    0.92   .1583
  Hypertension                                                                                                                                            
  No                               130                    153 414       0.08             1.00                                  1.00                       
  Yes                              175                    80 059        0.22             **2.58**    2.06    3.24    \<.0001   **1.25**    1.62    0.96   .0929
  Malignancy                                                                                                                                              
  No                               287                    223 494       0.13             1.00                                  1.00                       
  Yes                              18                     9979          0.18             **1.40**    0.87    2.26    .1616     **0.93**    1.61    0.54   .8009
  **Charlson Comorbidity Score**                                                                                                                          
  0                                140                    142 097       0.10             1.00                                  1.00                       
  1                                89                     57 174        0.16             **1.58**    1.21    2.06    .0007     **1.02**    1.34    0.77   .8893
  2                                43                     22 228        0.19             **1.96**    1.40    2.76    .0001     **0.98**    1.41    0.69   .9271
  Over 3                           33                     11 974        0.28             **2.80**    1.92    4.09    \<.0001   **0.97**    1.61    0.58   .8956

3.4. Cardiovascular complications and mortality {#clc23276-sec-0015}
-----------------------------------------------

New‐onset AF, AHF and IHD had an IRR for 3‐month mortality of 1.3, 2.4, and 13.7, respectively, after controlling for demographic factors and comorbidities. Increased age over 50 years also had an increased IRR of 1.8 to 10.2 for 3‐month mortality, and those admitted to the ICU had an IRR for 3‐month mortality of 4.5. Interestingly, those with better economic or health status also showed a lower IRR for mortality than those with poorer economic or health status (Table [4](#clc23276-tbl-0004){ref-type="table"}, Figure [1](#clc23276-fig-0001){ref-type="fig"}C).

###### 

Incidence risk ratio of demographic characteristics and comorbidities for mortality in scrub typhus patients

                                   Cumulative incidence   Crude model   Adjusted model                                                                      
  -------------------------------- ---------------------- ------------- ---------------- ----------- ------- -------- --------- ----------- ------- ------- ---------
  **New‐onset AF**                                                                                                                                          
  No                               1347                   231 071       0.58             1.00                                   1.00                        
  Yes                              105                    2402          4.37             **7.50**    6.17    9.11     \<.0001   **1.34**    1.07    1.68    .0106
  **Acute heart failure**                                                                                                                                   
  No                               1243                   229 754       0.54             1.00                                   1.00                        
  Yes                              209                    3719          5.62             **10.39**   9.00    11.98    \<.0001   **2.41**    2.04    2.84    \<.0001
  **Ischemic heart disease**                                                                                                                                
  No                               1292                   233 168       0.55             1.00                                   1.00                        
  Yes                              160                    305           52.46            **94.67**   83.98   106.73   \<.0001   **13.72**   11.03   17.07   \<.0001
  **Age**                                                                                                                                                   
  20‐49                            62                     48 519        0.13             1.00                                   1.00                        
  50‐59                            121                    53 480        0.23             **1.77**    1.30    2.40     .0003     **1.80**    1.33    2.44    .0001
  60‐69                            217                    60 676        0.36             **2.80**    2.11    3.71     \<.0001   **2.39**    1.79    3.18    \<.0001
  70‐79                            569                    53 648        1.06             **8.30**    6.39    10.78    \<.0001   **5.33**    4.06    7.02    \<.0001
  Over 80                          483                    17 150        2.82             **22.04**   16.93   28.69    \<.0001   **10.29**   7.76    13.65   \<.0001
  **Sex**                                                                                                                                                   
  Male                             751                    96 071        0.78             **1.53**    1.38    1.70     \<.0001   **1.68**    1.51    1.87    \<.0001
  Female                           701                    137 402       0.51             1.00                                   1.00                        
  **Insurance**                                                                                                                                             
  Medical aids                     181                    12 883        1.41             1.00                                   1.00                        
  Health insurance                                                                                                                                          
  1Q                               233                    38 844        0.60             **0.43**    0.35    0.52     \<.0001   **0.77**    0.63    0.94    .0118
  2Q                               215                    42 517        0.51             **0.36**    0.30    0.44     \<.0001   **0.73**    0.60    0.90    .0033
  3Q                               308                    58 837        0.52             **0.37**    0.31    0.45     \<.0001   **0.70**    0.58    0.85    .0002
  4Q                               515                    80 392        0.64             **0.46**    0.39    0.54     \<.0001   **0.63**    0.52    0.75    \<.0001
  **Residential area**                                                                                                                                      
  Metropolitan                     302                    58 200        0.52             1.00                                   1.00                        
  Non‐metropolitan                 1150                   175 273       0.66             **0.79**    0.70    0.90     .0003     **0.86**    0.75    0.98    .0292
  **Institution**                                                                                                                                           
  Outpatient care                  72                     96 057        0.08             1.00                                   1.00                        
  Admission                                                                                                                                                 
  **Antibiotics**                                                                                                                                           
  Doxycycline                      952                    218 791       0.44             1.00                                   1.00                        
  Azithromycin                     310                    8910          3.48             **8.00**    7.05    9.07     \<.0001   **3.43**    2.97    3.96    \<.0001
  Both                             190                    5772          3.29             **7.57**    6.49    8.82     \<.0001   **2.45**    2.07    2.90    \<.0001
  **ICU care**                                                                                                                                              
  No                               1241                   231 131       0.54             1.00                                   1.00                        
  Yes                              211                    2342          9.01             **16.78**   14.59   19.30    \<.0001   **4.51**    3.77    5.39    \<.0001
  **Medical history**                                                                                                                                       
  Past scrub typhus                                                                                                                                         
  No                               1388                   226 173       0.61             1.00                                   1.00                        
  Yes                              64                     7300          0.88             **1.43**    1.11    1.83     .0051     **1.19**    0.91    1.55    .213
  Congestive heart failure                                                                                                                                  
  No                               1385                   230 500       0.60             1.00                                   1.00                        
  Yes                              67                     2973          2.25             **3.75**    2.94    4.78     \<.0001   **1.45**    1.10    1.91    .0083
  Ischemic heart disease                                                                                                                                    
  No                               1294                   219 478       0.59             1.00                                   1.00                        
  Yes                              158                    13 995        1.13             **1.91**    1.62    2.26     \<.0001   **1.01**    0.85    1.20    .9023
  Stroke                                                                                                                                                    
  No                               1316                   225 118       0.58             1.00                                   1.00                        
  Yes                              136                    8355          1.63             **2.78**    2.34    3.32     \<.0001   **1.10**    0.91    1.32    .3361
  Chronic kidney disease                                                                                                                                    
  No                               1412                   232 352       0.61             1.00                                   1.00                        
  Yes                              40                     1121          3.57             **5.87**    4.31    8.00     \<.0001   **1.18**    0.81    1.72    .3797
  Diabetes mellitus                                                                                                                                         
  No                               1120                   202 401       0.55             1.00                                   1.00                        
  Yes                              332                    31 072        1.07             **1.93**    1.71    2.18     \<.0001   **1.29**    1.13    1.47    .0001
  Hypertension                                                                                                                                              
  No                               704                    153 414       0.46             1.00                                   1.00                        
  Yes                              748                    80 059        0.93             **2.04**    1.84    2.26     \<.0001   **0.94**    0.84    1.06    .3192
  Malignancy                                                                                                                                                
  No                               1327                   223 494       0.59             1.00                                   1.00                        
  Yes                              125                    9979          1.25             **2.11**    1.76    2.53     \<.0001   **0.99**    0.77    1.26    .9164
  **Charlson Comorbidity Score**                                                                                                                            
  0                                565                    142 097       0.40             1.00                                   1.00                        
  1                                443                    57 174        0.77             **1.95**    1.72    2.21     \<.0001   **1.32**    1.16    1.49    \<.0001
  2                                227                    22 228        1.02             **2.57**    2.20    2.99     \<.0001   **1.31**    1.11    1.55    .0015
  Over 3                           217                    11 974        1.81             **4.56**    3.90    5.32     \<.0001   **1.76**    1.43    2.17    \<.0001

4. DISCUSSION {#clc23276-sec-0016}
=============

In this nationwide scrub typhus infection cohort, patients with new‐onset AF were more likely to be hospitalized in the ICU and had higher 3‐month mortality rates. In particular, new‐onset AF was significantly associated with concurrent AHF or IHD during treatment for scrub typhus infection. Unlike the adverse cardiac complications occurring as a result of common infections,[16](#clc23276-bib-0016){ref-type="ref"}, [17](#clc23276-bib-0017){ref-type="ref"} evidence to date has been unclear concerning an association between scrub typhus infection and adverse cardiac outcomes.[11](#clc23276-bib-0011){ref-type="ref"} The present study is the first to demonstrate that new‐onset AF was significantly associated with 3‐month mortality and adverse cardiac complications in scrub typhus infection.

Occurrence of new‐onset AF has been known to be associated with infection which may be triggered by acute inflammatory condition.[18](#clc23276-bib-0018){ref-type="ref"} In critically‐ill patients with common infectious diseases, new‐onset AF has been reported to be significantly associated with all‐cause mortality in the ICU.[10](#clc23276-bib-0010){ref-type="ref"}, [19](#clc23276-bib-0019){ref-type="ref"} The FROG‐ICU trial demonstrated that new‐onset AF occurred in 19% of all patients in the ICU and had an incidence risk of 2.2‐fold for 1‐year mortality compared to those without new‐onset AF.[20](#clc23276-bib-0020){ref-type="ref"} The present study demonstrates that new‐onset AF occurred in the 7.7% of all patients in the ICU and had an incidence risk of 4.5‐fold for 3‐month mortality compared to those without new‐onset AF. It is noteworthy that new‐onset AF in scrub typhus infection developed less frequently, but had a higher risk of mortality than in the other infectious diseases. The reason for the higher mortality and adverse cardiac complications could be explained by the unique pathophysiology of scrub typhus infection,[17](#clc23276-bib-0017){ref-type="ref"} which initiates at the site of skin inoculation, evolves into regional lymphadenopathy and spreads to vasculitis with subsequent target organ damage.[21](#clc23276-bib-0021){ref-type="ref"} Subsequently, induced myocardial inflammation could develop electrical, functional, and structural remodeling during the pathogenesis of new‐onset AF and AHF.[22](#clc23276-bib-0022){ref-type="ref"}, [23](#clc23276-bib-0023){ref-type="ref"}, [24](#clc23276-bib-0024){ref-type="ref"}, [25](#clc23276-bib-0025){ref-type="ref"}, [26](#clc23276-bib-0026){ref-type="ref"} The present study also demonstrates that AHF concurrent with new‐onset AF could develop within only a few days of the index diagnosis of scrub typhus infection (Figure [1](#clc23276-fig-0001){ref-type="fig"}A). In addition, new‐onset AF was also associated with a greater risk for developing IHD in the critically‐ill status including complicating scrub typhus infection.[11](#clc23276-bib-0011){ref-type="ref"}, [27](#clc23276-bib-0027){ref-type="ref"}, [28](#clc23276-bib-0028){ref-type="ref"} Coronary vasculitis also might induce direct endothelial dysfunction and vascular injury causing atherosclerotic plaque growth or rupture during the pathogenesis of IHD.[29](#clc23276-bib-0029){ref-type="ref"}, [30](#clc23276-bib-0030){ref-type="ref"} In particular, ECG or rhythm surveillance for cardiac complications could be a necessary monitoring of scrub typhus infection because of the risk of developing atrial or ventricular arrhythmia and changes in the ST segment of ECG as a result of active inflammation in the myocardium.[11](#clc23276-bib-0011){ref-type="ref"} Available ECG‐based new‐onset AF or ST segment change could be more readily evaluated[31](#clc23276-bib-0031){ref-type="ref"} than time and cost‐consuming echocardiogram‐based AHF or angiogram‐based IHD[32](#clc23276-bib-0032){ref-type="ref"} under the care of non‐cardiologic department. ECG or rhythm‐based surveillance for the development of cardiac complications is crucial for preventing scrub typhus infection from developing life‐threatening outcomes.[33](#clc23276-bib-0033){ref-type="ref"} This could provide an additional method for reducing adverse cardiac complications in scrub typhus infection.

4.1. Limitations {#clc23276-sec-0017}
----------------

There are several limitations to the present study. First, the national cohort data does not include lifestyle information, such as alcohol intake, smoking habits, body mass index or family history, all of which are potential confounding factors in this study. Second, old age, hypertension, diabetes and previous HF are well‐known comorbidities strongly correlated with new‐onset AF. Therefore, we adjusted for these comorbidities to minimize the influence of AHF or IHD on 3‐month mortality. Third, living in a metropolitan area or being treated with azithromycin for a refractory or complicated type of scrub typhus infection also might induce treatment bias. Fourth, the cohort data were selected according to ICD codes, which may potentially have misclassification bias. Fifth, there was no control group of patients without scrub typhus infection. Therefore, our results might not be fully generalizable, and a prospective, randomized controlled trial should be conducted to overcome these limitations.

5. CONCLUSION {#clc23276-sec-0018}
=============

New‐onset AF was significantly associated with 3‐month mortality and concurrent cardiac adverse outcomes. Therefore, new‐onset AF may be a poor prognostic factor for 3‐month mortality and adverse cardiac complications in scrub typhus infection. Further investigation is warranted to prospectively validate these results.
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